Jonathan Wogel

Jonathan has over 35 years of global pharma, device & biotech M&A, JV licensing, and scale-up experience, with over 26 years as an expat. He has developed over £4Bn in M&A deals for private and PE-backed businesses and launched/licensed over 50 products globally.

The last 12 years have been focused on helping SMEs and startups with seed/Series A, B, and Angel/PE based fundraising by developing and implementing business and commercial strategies to drive scale.

Jonathan has an undergraduate degree in Biochemistry and also holds an MBA, MPH, and a Ph.D. (Health Economics) He is also the Executive Chair & a Director of Zentraxa, a biomaterials spin-out from the University of Bristol.